Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by mollevi
Group name EquipeJC
Item Type Note
Note The following values have no corresponding Zotero field:
auth-address: CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna 1090, Austria. 1] CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna 1090, Austria [2] Department of Immunology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo 05508-900, Brazil. Department of Pediatric Immunology and Allergy, Ankara University Medical School, Ankara 06100, Turkey. Center for Human Immunobiology, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas 77030, USA. Centre of Chronic Immunodeficiency, University Medical Centre Freiburg, Freiburg 79180, Germany. Department of Pediatric Hematology, Akdeniz University Medical School, Antalya 07985, Turkey. Department of Immunology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo 05508-900, Brazil. Christian Doppler Laboratory for Immunomodulation and Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna 1090, Austria. Department of Immunology, Erasmus MC, University Medical Center, Rotterdam 3015GE, The Netherlands. 1] CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna 1090, Austria [2] Department of Paediatrics and Adolescent Medicine, Medical University of Vienna, Vienna 1090, Austria.
alt-title: Nature communications
accession-num: 25406581
Tags _EndnoteXML import
Date Added 2018/11/14 - 11:48:35
Date Modified 2018/11/14 - 11:48:35
Parent item Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés